Patent Applications published on Sep 28, 2023 - page 3

#601
US20230301829A1
Human necessities

INJECTION DEVICE WITH BOTH LINEAR AND ROTARY INDEPENDENT MOTOR DRIVES

#602
US20230301830A1
Human necessities

DRUG-ELUTING OCULAR IMPLANT

#603
US20230301831A1
Human necessities

MULTI-DOSE OCULAR FLUID DELIVERY SYSTEM

#604
US20230301832A1
Human necessities

OPHTHALMIC DEVICE

#605
US20230301833A1
Human necessities

SURGICAL IMPLANT DELIVERY WITH DUAL MODE DRIVE

#606 ✅ Patent 12,161,530 granted on 2024-12-10
US20230301834A1
Human necessities

Wound therapy system with wound volume estimation using geometric approximation

#607
US20230301835A1
Human necessities

LOW-GROWTH TISSUE INTERFACE

#608
US20230301836A1
Human necessities

DRESSINGS HAVING SELECTABLE ADHESIVE FOR USE WITH INSTILLATION THERAPY AND NEGATIVE-PRESSURE THERAPY

#609
US20230301837A1
Human necessities

WOUND CLOSURE DEVICE WITH PROTECTIVE LAYER AND METHOD OF USE

#610 ✅ Patent 12,239,509 granted on 2025-03-04
US20230301838A1
Human necessities

Negative pressure wound closure device

#611
US20230301839A1
Human necessities

NASAL COMPRESSION DEVICE

#612 ✅ Patent 12,059,329 granted on 2024-08-13
US20230301840A1
Human necessities

Methods and apparatuses for making elastomeric laminates with elastic strands provided with a spin finish

#613
US20230301841A1
Human necessities

A METHOD AND APPARATUS FOR PRODUCING FLUFF-FREE ABSORBENT CORES

#614
US20230301842A1
Human necessities

BI-DIRECTIONALLY POSITIONABLE TAMPON

#615
US20230301843A1
Human necessities

TAMPON/SUPPOSITORY HYBRID

#616
US20230301845A1
Human necessities

DISPOSABLE WEARABLE ARTICLE

#617
US20230301846A1
Human necessities

MATERIALS AND METHODS OF MANUFACTURING RELATED TO APPARATUS FOR COLLECTING URINE

#618
US20230301847A1
Human necessities

AMBULANCE HAVING INFECTIOUS DISEASE BLOCKING FUNCTION, AND INTERIOR PRESSURE CONTROL METHOD THEREFOR

#619
US20230301848A1
Human necessities

ACCESSIBILITY VEHICLE

#620
US20230301849A1
Human necessities

WHEELCHAIR RESTRAINT SYSTEMS AND METHOD THEREOF

#621 ✅ Patent 11,998,496 granted on 2024-06-04
US20230301850A1
Human necessities

Power transmission mechanism

#622
US20230301851A1
Human necessities

SEATING SYSTEM

#623
US20230301852A1
Human necessities

CONVERTIBLE WHEELCHAIR COMPRISING SLIDE SEAT

#624
US20230301853A1
Human necessities

MEDICAL AUTOMATIC TURNOVER BED

#625
US20230301854A1
Human necessities

ANTI-DECUBITUS DEVICE AND ANTI-DECUBITUS SYSTEM

#626 ✅ Patent 12,329,702 granted on 2025-06-17
US20230301855A1
Human necessities

Emergency Lifting Apparatus

#627 ✅ Patent 11,969,386 granted on 2024-04-30
US20230301856A1
Human necessities

Patient slider device

#628
US20230301857A1
Human necessities

WHEELCHAIR LIFT DEVICE AND USE THEREOF

#629
US20230301858A1
Human necessities

METHODS OF PREPARING A SUBJECT FOR ROTATION AND ROTATING A SUBJECT USING AN OVERHEAD LIFT

#630
US20230301859A1
Human necessities

ARTICULATING BED CONVERTIBLE TO ASSIST CHAIR

#631
US20230301860A1
Human necessities

HYPERBARIC OXYGEN CHAMBER MANUFACTURED UTILITIZING ADDITIVE MANUFACTURING

#632 ✅ Patent 12,285,367 granted on 2025-04-29
US20230301861A1
Human necessities

Configurable assembly for providing medical care to a patient

#633 ✅ Patent 11,925,586 granted on 2024-03-12
US20230301862A1
Human necessities

Surgical platform and trolley assembly

#634
US20230301863A1
Human necessities

MATTRESS AND CONTROL METHOD THEREOF

#635
US20230301864A1
Human necessities

TECHNOLOGIES FOR IMPROVING THE GAIT OF INDIVIDUALS WITH PARKINSON'S DISEASE

#636
US20230301865A1
Human necessities

Cane Tip Attachment for a Safety Cane

#637
US20230301866A1
Human necessities

Anti-Pinch Massage Device And Massage Head

#638
US20230301867A1
Human necessities

PERCUSSIVE MASSAGE DEVICE

#639
US20230301868A1
Human necessities

LIGHT THERAPY FOR SPA

#640
US20230301869A1
Human necessities

DEVICE FOR ACUPUNCTURE AND MOXIBUSTION THERAPY AND USES THEREOF

#641
US20230301870A1
Human necessities

Container With Threaded Connector

#642
US20230301871A1
Human necessities

Membrane for Closed System Transfer Device

#643 ✅ Patent 11,963,928 granted on 2024-04-23
US20230301872A1
Human necessities

Glass containers for storing pharmaceutical compositions

#644 ✅ Patent 12,076,297 granted on 2024-09-03
US20230301873A1
Human necessities

Glass containers for storing pharmaceutical compositions

#645
US20230301874A1
Human necessities

BINARY CONNECTOR FOR RECONSTITUTION

#646
US20230301875A1
Human necessities

SYSTEM AND METHOD FOR PREPARATION AND DELIVERY OF RE-GENERATIVE FIBRIN MATRICES

#647 ✅ Patent 12,186,273 granted on 2025-01-07
US20230301876A1
Human necessities

Systems and methods for portable pill dispensers with various dispensing mechanisms

#648
US20230301877A1
Human necessities

MEDICAL PUMP

#649
US20230301878A1
Human necessities

COATED POWDER FOR POWDER JET CLEANING OF TEETH

#650
US20230301879A1
Human necessities

OIL-IN-WATER EMULSION COMPOSITION

#651 ✅ Patent 12,311,042 granted on 2025-05-27
US20230301880A1
Human necessities

Ink composition for hair dyeing, film for hair dyeing, film cartridge for hair dyeing, and printer for hair dyeing

#652
US20230301881A1
Human necessities

PERSONAL CARE COMPOSITIONS WITH ANTIMICROBIAL, HYDRODYNAMIC, AND ANTIOXIDANT NANOPARTICLES

#653
US20230301882A1
Human necessities

CALCIUM CARBONATE AND ZINC OXIDE-LOADED MICROCAPSULES AND USES THEREOF

#654
US20230301883A1
Human necessities

MOISTURIZING ANTIBACTERIAL COMPOSITION

#655
US20230301884A1
Human necessities

ANTISEPTIC COMPOSITIONS

#656
US20230301885A1
Human necessities

NOVEL USE

#657
US20230301886A1
Human necessities

MOISTURIZING ANTIBACTERIAL COMPOSITION

#658 ✅ Patent 11,957,774 granted on 2024-04-16
US20230301887A1
Human necessities

Composition for enhancing keratin fibers

#659
US20230301888A1
Human necessities

POLYMER/HYDROPHOBIC ESTER OIL BLEND

#660
US20230301889A1
Human necessities

METHOD OF PREVENTING OR REDUCING HAIR FALL

#661
US20230301890A1
Human necessities

COMPOSITIONS COMPRISING UROLITHINS

#662
US20230301891A1
Human necessities

COMPOSITIONS AND METHODS FOR STYLING HAIR

#663
US20230301892A1
Human necessities

COMPOSITIONS AND METHODS FOR ELONGATING CURLY HAIR

#664
US20230301893A1
Human necessities

Hair Growth and Scalp Preparations

#665 ✅ Patent 12,115,242 granted on 2024-10-15
US20230301894A1
Human necessities

Peptide composition and respective uses

#666
US20230301895A1
Human necessities

NAIL FORMULATIONS AND TREATMENT REGIMES

#667
US20230301896A1
Human necessities

COMPOSITION FOR PENETRATING SUGAR BASED DELIVERY SYSTEM

#668
US20230301897A1
Human necessities

CELLULOSE ACETATE PARTICLES, COSMETIC COMPOSITION, AND METHOD FOR PRODUCING CELLULOSE ACETATE PARTICLES

#669
US20230301898A1
Human necessities

EMULSIFIER COMPOSITION FOR PERSONAL CARE FORMULATION

#670
US20230301899A1
Human necessities

EXTRACT OF SPIRODELA POLYRHIZA AND ITS COSMETIC USES

#671
US20230301900A1
Human necessities

(54) Title: METHOD FOR MANUFACTURING PLANT FERMENTED PRODUCT USING PLANT FERMENTED BROTH

#672
US20230301901A1
Human necessities

USE OF IL-22 DIMER IN MANUFACTURE OF A MEDICAMENT FOR INTRAVENOUS ADMINISTRATION

#673
US20230301902A1
Human necessities

IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE

#674 ✅ Patent 12,171,868 granted on 2024-12-24
US20230301903A1
Human necessities

Intranasal olanzapine formulations and methods of their use

#675
US20230301904A1
Human necessities

Formulation for Treating Ophthalmic Conditions

#676
US20230301905A1
Human necessities

INHALABLE THERAPEUTIC AGENTS

#677
US20230301906A1
Human necessities

BIOCOMPATIBLE, INJECTABLE AND IN SITU GELLING HYDROGELS AND PREPARATION AND APPLICATIONS OF BIOCOMPATIBLE, INJECTABLE AND IN SITU GELLING HYDROGELS BASED ON CELLULOSE NANOFIBRILS FOR TISSUE AND ORGAN REPAIR

#678
US20230301907A1
Human necessities

COMPOSITION AND METHOD FOR VANCOMYCIN ORAL LIQUID

#679
US20230301908A1
Human necessities

CONTACT LENS PRODUCT HAVING ANTIOXIDATIVE FUNCTION

#680
US20230301909A1
Human necessities

NICOTINAMIDE-ENCAPSULATING MICELLES, AND PREGNANCY-INDUCED HYPERTENSION SYNDROME THERAPY COMPOSITION CONTAINING NICOTINAMIDE-ENCAPSULATING MICELLES

#681
US20230301910A1
Human necessities

SOLID MATERIAL AND DISPERSION COMPOSITION CONTAINING SAME

#682
US20230301911A1
Human necessities

COMPOSITION FOR PROMOTING DRUG RELEASE OF DRUG-DELIVERY LIPOSOMES

#683 ✅ Patent 12,064,511 granted on 2024-08-20
US20230301912A1
Human necessities

Lipid nanoparticles containing silyl lipids for use in vaccines and gene therapy

#684 ✅ Patent 12,064,512 granted on 2024-08-20
US20230301913A1
Human necessities

Silyl lipids suitable for enhanced delivery of anti-viral therapeutics

#685
US20230301914A1
Human necessities

PHARMACEUTICAL COMPOSITIONS IN LYOPHILIZED FORM

#686
US20230301915A1
Human necessities

LIPOSOMIC DRUG-DELIVERY VEHICLES

#687 ✅ Patent 12,144,890 granted on 2024-11-19
US20230301916A1
Human necessities

Manufacturing of bupivacaine multivesicular liposomes

#688 ✅ Patent 12,357,571 granted on 2025-07-15
US20230301917A1
Human necessities

LOADING OF EXTRACELLULAR VESICLES THROUGH IMPARTING OF MECHANICAL SHEAR

#689 ✅ Patent 12,102,717 granted on 2024-10-01
US20230301918A1
Human necessities

Hollow silica spheres with nested iron oxide particles

#690
US20230301919A1
Human necessities

FREEZE DRIED LOW HYGROSCOPICITY ACTIVE POWDER COMPOSITIONS

#691
US20230301920A1
Human necessities

HYDROXYALKYLALKYL CELLULOSE FOR TABLETING AND SOLID PREPARATION COMPRISING THE SAME

#692 ✅ Patent 11,911,512 granted on 2024-02-27
US20230301921A1
Human necessities

Encased tamper resistant controlled release dosage forms

#693
US20230301922A1
Human necessities

Layered Pharmaceutical Formulations

#694 ✅ Patent 12,064,521 granted on 2024-08-20
US20230301923A1
Human necessities

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

#695
US20230301924A1
Human necessities

PHARMACEUTICAL FORMULATION

#696
US20230301925A1
Human necessities

PHOSPHOLIPID PRESENTING PARTICLES FOR CELL TARGETING IN THERAPY AND DIAGNOSTICS

#697
US20230301926A1
Human necessities

EXTRACELLULAR VESICLES WITH IMPROVED HALF-LIFE

#698
US20230301927A1
Human necessities

PROCESS FOR PRODUCING AN ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION WITH COLONIC DELIVERY

#699 ✅ Patent 12,161,762 granted on 2024-12-10
US20230301928A1
Human necessities

Nanohelix-substrate complex for controlling macrophage behavior, preparation method thereof, and method of controlling adhesion and polarization of macrophage by using the same

#700
US20230301930A1
Human necessities

NANOPARTICLE CANCER THERAPY

#701
US20230301931A1
Human necessities

NANOPARTICULATE SYSTEM FOR TREATING ORAL CANCER

#702
US20230301932A1
Human necessities

MULTILAYER COMPOSITE MATERIAL

#703
US20230301933A1
Human necessities

USE OF PHENOL IN TREATMENT OF MICROBIALLY INDUCED DYSPNOEA

#704 ✅ Patent 12,263,139 granted on 2025-04-01
US20230301934A1
Human necessities

Use of cannabidiol in the treatment of tuberous sclerosis complex

#705 ✅ Patent 11,839,593 granted on 2023-12-12
US20230301935A1
Human necessities

Penetrating topical pain relief compositions and methods of use

#706 ✅ Patent 11,963,937 granted on 2024-04-23
US20230301936A1
Human necessities

Use of cannabinoids in the treatment of epilepsy

#707
US20230301938A1
Human necessities

TREATMENT OF COVID-19 ASSOCIATED COGNITIVE DYSFUNCTION BY NUTRACEUTICAL PREPARATIONS

#708
US20230301939A1
Human necessities

NOVEL FORMULATIONS COMPRISING KETAMINE

#709 ✅ Patent 11,992,468 granted on 2024-05-28
US20230301941A1
Human necessities

Abuse-deterrent dosage forms containing esketamine

#710
US20230301944A1
Human necessities

AMINOXY ACID-BASED ANTI-CANCER STEM CELL COMPOUNDS AND METHODS THEREOF

#711
US20230301945A1
Human necessities

STABLE PHARMACEUTICAL COMPOSITIONS OF HYDROXYUREA

#712
US20230301946A1
Human necessities

THROMBOXANE RECEPTOR ANTAGONIST FORMULATIONS

#713
US20230301947A1
Human necessities

COMPOUND FOR PREVENTING AND TREATING PSYCHIATRIC DISORDERS AND USE THEREOF

#714
US20230301948A1
Human necessities

REDUCTION OF VIRAL INFECTIONS

#715 ✅ Patent 12,357,598 granted on 2025-07-15
US20230301949A1
Human necessities

TREATMENT OF NEURODEVELOPMENTAL DISORDERS

#716
US20230301950A1
Human necessities

METHOD FOR SELECTING CANCER PATIENTS FOR WHOM COMBINATION THERAPY WITH RETINOID AND CANCER THERAPEUTIC AGENT IS EFFECTIVE, AND COMBINATION MEDICAMENT WITH RETINOID AND CANCER THERAPEUTIC AGENT

#717
US20230301951A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS

#718 ✅ Patent 12,257,219 granted on 2025-03-25
US20230301952A1
Human necessities

Storage stable aqueous parenteral solutions comprising diclofenac

#719
US20230301953A1
Human necessities

COMPOSITION FOR PREVENTION AND TREATMENT OF MYOPATHY

#720
US20230301954A1
Human necessities

Method of Metabolic Enhancement and Composition Manufacture

#721
US20230301955A1
Human necessities

RESPIRATORY TRACT DELIVERY OF LEVODOPA AND DOPA DECARBOXYLASE INHIBITOR FOR TREATMENT OF PARKINSON'S DISEASE

#722
US20230301956A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATMENT OF INFLAMMATORY DISEASE

#723
US20230301957A1
Human necessities

POLYGLYCEROL FATTY ACID ESTER COMPOSITION AND APPLICATION THEREOF

#724
US20230301958A1
Human necessities

SATRAPLATIN FOR USE IN THE TREATMENT OF LYMPHOID NEOPLASMS

#725
US20230301959A1
Human necessities

COMBINATIONS OF CARNOSINE AND ZINC FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS

#726 ✅ Patent 12,208,078 granted on 2025-01-28
US20230301960A1
Human necessities

Tiglien-3-one derivatives

#727
US20230301961A1
Human necessities

A19-144, A2-73 and Certain Anticholinesterase Inhibitor Compositions and Method for Anti-Seizure Therapy

#728
US20230301965A1
Human necessities

METHODS AND COMPOSITIONS RELATING TO INHIBITION OF ALDEHYDE DEHYDROGENASES FOR TREATMENT OF CANCER

#729
US20230301966A1
Human necessities

METHOD OF ENHANCING 5-HYDROXYTRYPTOPHAN (5-HTP) EXPOSURE

#730
US20230301967A1
Human necessities

METHODS AND COMPOSITIONS FOR THE TREATMENT OF RETINOPATHY AND OTHER OCULAR DISEASES

#731
US20230301968A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING FLUBENDAZOLE

#732
US20230301969A1
Human necessities

DOSING SCHEDULE FOR A METHOD OF TREATMENT WITH DHODH INHIBITORS

#733
US20230301970A1
Human necessities

CARBOXAMIDE DERIVATIVES

#734 ✅ Patent 12,213,964 granted on 2025-02-04
US20230301971A1
Human necessities

Isoxazoline parasiticide formulations

#735
US20230301972A1
Human necessities

ANTI-FIBROTIC COMPOSITION AND RELATED METHODS

#736
US20230301973A1
Human necessities

TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA

#737
US20230301974A1
Human necessities

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

#738 ✅ Patent 11,963,953 granted on 2024-04-23
US20230301975A1
Human necessities

Deuterated compounds for restoring mutant p53 function

#739
US20230301977A1
Human necessities

WOUND HEALING MODEL

#740 ✅ Patent 12,016,854 granted on 2024-06-25
US20230301978A1
Human necessities

Liquid dosage forms to treat cancer

#741
US20230301979A1
Human necessities

COMBINATIONS FOR THE TREATMENT OF CANCER

#742 ✅ Patent 11,969,419 granted on 2024-04-30
US20230301980A1
Human necessities

Method of treating cancer

#743
US20230301981A1
Human necessities

TLR7/8 ANTAGONISTS AND USES THEREOF

#744
US20230301982A1
Human necessities

N'-(2-CHLORO-6-METHYLBENZOYL)-4-METHYL-3-[2-(3-QUINOLYL)ETHYNYL]-BENZOHYDRAZIDE FOR TREATMENT OF ALZHEIMER'S DISEASE

#745
US20230301983A1
Human necessities

BROMODOMAIN INHIBITOR

#746
US20230301984A1
Human necessities

CYCLIC COMPOUNDS FOR USE IN TREATING RETINAL DEGENERATION

#747
US20230301985A1
Human necessities

MOVEMENT DISORDERS

#748 ✅ Patent 12,011,440 granted on 2024-06-18
US20230301986A1
Human necessities

Ready-to-administer hydromorphone formulations

#749
US20230301987A1
Human necessities

SUSTAINED FORMULATION FOR PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE CONTAINING LOW-DOSE NALTREXONE AND METHOD USING THE SAME

#750
US20230301988A1
Human necessities

INHIBITORS OF SARS COV-2 INFECTION AND USES THEREOF

#751
US20230301989A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

#752
US20230301990A1
Human necessities

CERTAIN ARYL PLADIENOLIDE COMPOUNDS AND METHODS OF USE

#753
US20230301991A1
Human necessities

COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS

#754 ✅ Patent 11,938,130 granted on 2024-03-26
US20230301992A1
Human necessities

Stable pharmaceutical composition for oral administration

#755
US20230301993A1
Human necessities

Low-Dose Ophthalmic Compositions and Methods

#756
US20230301994A9
Human necessities

BICYCLIC COMPOUNDS AND METHODS FOR THEIR USE IN TREATING PITT HOPKINS SYNDROME

#757 ✅ Patent 12,268,686 granted on 2025-04-08
US20230301995A1
Human necessities

Transmucosal methods for treating psychiatric and neurological conditions

#758 ✅ Patent 11,890,284 granted on 2024-02-06
US20230301997A1
Human necessities

Carbon dioxide shampoo apparatus and method of use thereof

#759
US20230301998A1
Human necessities

METHODS AND COMPOSITIONS FOR INDUCTION OF ANTITUMOR IMMUNITY

#760
US20230301999A1
Human necessities

METHODS OF TREATING GOUT

#761
US20230302000A1
Human necessities

COMBINATION DRUG TREATMENT TO INCREASE NEUROGENESIS FOR NEUROLOGICAL DISORDERS

#762
US20230302001A1
Human necessities

PRESERVATION OF IMMUNE RESPONSE DURING CHEMOTHERAPY REGIMENS

#763
US20230302002A1
Human necessities

Pharmaceutical Compositions and Methods for Stabilizing the Same

#764
US20230302003A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING A CORONAVIRUS INFECTION

#765
US20230302005A1
Human necessities

ACTIVE PHARMACEUTICAL INGREDIENT, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME

#766
US20230302008A1
Human necessities

METHODS OF ADMINISTERING INTRAVENOUS MELOXICAM IN A BOLUS DOSE

#767
US20230302009A1
Human necessities

BACE1 INHIBITOR TREATMENT FOR SUPPRESSING CYTOKINE STORM

#768
US20230302010A1
Human necessities

2-((4S)-6-(4-CHLOROPHENYL)-1-METHYL-4H-BENZO[C]ISOXAZOLO[4,5-E]AZEPIN-4-YL)ACETAMIDE FOR TREATING THROMBOCYTHEMIA

#769 ✅ Patent 11,771,704 granted on 2023-10-03
US20230302011A1
Human necessities

Methods of using rho kinase inhibitors to treat alzheimer's disease

#770
US20230302012A1
Human necessities

Treating Progressive Familial Intrahepatic Cholestasis (PFIC) with IBAT Inhibitors

#771
US20230302013A1
Human necessities

METHOD OF TREATING VIRAL-INDUCED COGNITIVE DYSFUNCTION BY TARGETING LEAKY RyR2 CHANNELS

#772
US20230302014A1
Human necessities

USES OF GLUCOCORTICOID RECEPTOR (GR) ANTAGONIST AND ANDROGEN RECEPTOR (AR) DEGRADER COMBINATIONS

#773
US20230302015A1
Human necessities

NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES

#774 ✅ Patent 12,102,643 granted on 2024-10-01
US20230302016A1
Human necessities

Aqueous pharmaceutical formulation of hydrocortisone sodium phosphate and monothioglycerol

#775
US20230302017A1
Human necessities

INOTODIOL AS AGONIST OF LIVER X RECEPTORS, AND USE THEREOF

#776 ✅ Patent 12,343,351 granted on 2025-07-01
US20230302018A1
Human necessities

PULMONARY FUNCTION TREATMENT

#777
US20230302019A1
Human necessities

COMPOUND FOR TREATING AND/OR PREVENTING DISEASES CAUSED BY CORONAVIRUS AND USE THEREOF

#778
US20230302020A1
Human necessities

TRANSPORE DELIVERY OF STEROIDS AND LARGE MOLECULES

#779
US20230302021A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CASTRATION-RESISTANT PROSTATE CANCER

#780
US20230302022A1
Human necessities

PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D

#781
US20230302023A1
Human necessities

ANTI-ACNE SKIN CARE COMPOSITIONS

#782
US20230302024A1
Human necessities

DARUNAVIR COMBINATION FORMULATIONS

#783
US20230302025A1
Human necessities

METHODS FOR MAINTAINING MICROVASCULAR INTEGRITY

#784
US20230302026A1
Human necessities

IMMUNOMODULATION FORMULATIONS AND RELATED METHODS

#785
US20230302027A1
Human necessities

HOMOGENEOUS HASHISH PRODUCT

#786
US20230302028A1
Human necessities

PAIN-RELIEVING TOPICAL COMPOSITIONS

#787
US20230302029A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVING GUT HEALTH

#788
US20230302030A1
Human necessities

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPase

#789
US20230302031A1
Human necessities

Modulators Of Purinergic Receptors and Related Immune Checkpoint For Treating Acute Respiratory Distress Syndrome

#790
US20230302032A1
Human necessities

ANTIBACTERIAL COMPOSITIONS AND METHODS FOR FABRICATING THEREOF

#791
US20230302033A1
Human necessities

FORMULATIONS OF NICOTINIC ACID DERIVATIVES AND FLAVONOID POLYPHENOLS AND USES THEREOF

#792
US20230302034A1
Human necessities

Methods And Compositions For Cancer Therapies That Include Delivery Of Halogenated Thymidines And Thymidine Phosphorylase Inhibitors In Combination With Radiation

#793
US20230302035A1
Human necessities

REPEAT RNA AS BIOMARKERS OF TUMOR IMMUNE RESPONSE

#794
US20230302036A1
Human necessities

COMPOSITIONS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY

#795
US20230302037A1
Human necessities

Blockade of miR466l-3p binding to IL-17A mRNA with site-specific target site blocker prevents neuro-inflammatory-mediated disease

#796 ✅ Patent 12,251,395 granted on 2025-03-18
US20230302038A1
Human necessities

RNAS for complement inhibition

#797
US20230302039A1
Human necessities

CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES

#798 ✅ Patent 12,029,751 granted on 2024-07-09
US20230302040A1
Human necessities

Therapeutic agent for nervous system disease

#799
US20230302041A1
Human necessities

Competitive Self-Blocking with Unlabeled Manocept Imaging Agents

#800
US20230302042A1
Human necessities

METHODS FOR THE PREVENTION OF CHOLESTEROL CRYSTAL EMBOLIZATION WITH CYCLODEXTRINS

#801
US20230302043A1
Human necessities

BIOMATERIAL COMPRISING POLY(ITACONATE-CO-CITRATE-CO-OCTANEDIOL)

#802
US20230302044A1
Human necessities

COMPOSITION TO INCREASE CELLULARLONGEVITY

#803
US20230302045A1
Human necessities

PHOSPHONATE-CONTAINING POLYMERS FOR VIRULENCE SUPPRESSION

#804 ✅ Patent 12,138,281 granted on 2024-11-12
US20230302046A1
Human necessities

Methods of treating chronic inflammatory diseases

#805 ✅ Patent 11,998,565 granted on 2024-06-04
US20230302047A1
Human necessities

Trace element compositions, methods of making and use

#806
US20230302048A1
Human necessities

NOVEL METHODS FOR INCREASING HEALING SPEED OF HUMAN AND ANIMAL WOUNDS

#807
US20230302049A1
Human necessities

METHODS FOR TREATING CANCER AND AUTOIMMUNE AND INFLAMMATORY DISEASES

#808
US20230302050A1
Human necessities

Single Domain Antibodies and Their Use in Cancer Therapies

#809
US20230302051A1
Human necessities

CHIMERIC ANTIGEN RECEPTORS (CARs), TARGETING HEMATOLOGIC MALIGNANCIES, COMPOSITIONS AND METHODS OF USE THEREOF

#810
US20230302052A1
Human necessities

METHODS FOR TREATING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

#811
US20230302053A1
Human necessities

MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY

#812
US20230302054A1
Human necessities

MODIFICATION OF T CELLS

#813
US20230302055A1
Human necessities

COMPOSITION FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES, METHOD FOR PRODUCING COMPOSITION FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES, AND METHOD FOR PRODUCING THERAPEUTIC FORMULATION FOR CENTRAL NERVOUS SYSTEM DISEASES

#814
US20230302056A1
Human necessities

ALLOGENEIC COMPOSITION FOR THE TREATMENT OF COVID-19

#815
US20230302057A1
Human necessities

COMPOSITIONS FOR ESTABLISHING MIXED CHIMERISM AND METHODS OF MANUFACTURE THEREOF

#816
US20230302058A1
Human necessities

TREATMENT OF LYMPHEDEMA AND RELATED CONDITIONS USING PLACENTAL ADHERENT CELLS

#817
US20230302059A1
Human necessities

UMBILICAL CORD-DERIVED ADHERENT STEM CELLS, PREPARATION METHOD THEREFOR, AND USE THEREOF

#818 ✅ Patent 12,090,178 granted on 2024-09-17
US20230302060A1
Human necessities

Methods for making mixed allergen compositions

#819
US20230302061A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS USING FOURNIERELLA MASSILIENSIS

#820
US20230302062A1
Human necessities

COMPOSITIONS COMPRISING BACTERIAL STRAINS

#821
US20230302063A1
Human necessities

Probiotic Formulations for Improving Athletic Performance

#822
US20230302064A1
Human necessities

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE GASTROINTESTINAL SYSTEM

#823
US20230302065A1
Human necessities

COMPOSITION WITH LACTOBACILLUS PARACASEI AND A METHOD TO TREAT NASOPHARYNGEAL CARCINOMA THROUGH PYROPTOSIS OR CELL CYCLE ARREST

#824
US20230302066A1
Human necessities

PROBIOTIC COMPOSITION FOR TREATMENT OF ORAL CANDIDA INFECTIONS

#825
US20230302067A1
Human necessities

PROBIOTIC COMPOSITIONS AND THEIR USE IN THE PREVENTION AND/OR TREATMENT OF SKIN DISEASES AND/OR DISORDERS

#826
US20230302068A1
Human necessities

PROBIOTIC SYSTEM AND USE THEREOF

#827
US20230302069A1
Human necessities

LACTIC ACID BACTERIA COMPOSITION STABLE UNDER STRONG ACIDIC CONDITIONS

#828
US20230302070A1
Human necessities

Cardiovascular Health-Promoting Composition

#829
US20230302071A1
Human necessities

ANTIDEPRESSANT COMPOSITION CONTAINING PLEUROTUS ERYNGII EXTRACT AS ACTIVE INGREDIENT

#830 ✅ Patent 11,744,868 granted on 2023-09-05
US20230302072A1
Human necessities

dextran, preparation method and application thereof

#831
US20230302073A1
Human necessities

BOTANICAL EXTRACTION

#832 ✅ Patent 12,156,896 granted on 2024-12-03
US20230302074A1
Human necessities

Methods for treating neurological disorders using nutrient compositions

#833
US20230302075A1
Human necessities

PREPARATIONS CONTAINING BERRY EXTRACTS FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF VIRAL INFECTIONS CAUSED BY CORONAVIRIDAE

#834
US20230302076A1
Human necessities

Natural and Organic Composition for Preventing Hair Loss and Promoting Hair Growth

#835
US20230302078A1
Human necessities

METHODS AND COMPOSITIONS FOR WEIGHT CONTROL

#836
US20230302079A1
Human necessities

SAPONIN CONTAINING EXTRACTS PREPARED FROM HESPERALOE USEFUL IN THE TREATMENT OF NON-HUMAN ANIMALS

#837
US20230302080A1
Human necessities

METHOD FOR PRODUCING A MAMMALIAN BRAIN PROTEIN HYDROLYSATE

#838
US20230302082A1
Human necessities

AGENT FOR REVERSIBLE OPENING OF NEURAL VASCULAR BARRIER

#839
US20230302083A1
Human necessities

HIGHLY-NETWORKED CORONAVIRUS IMMUNOGEN COMPOSITION

#840
US20230302084A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING PERIODONTAL DISEASE

#841
US20230302085A1
Human necessities

Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye Disorders

#842
US20230302089A1
Human necessities

CYTOKINE CONJUGATES FOR THE TREATMENT OF AUTOIMMUNE DISEASES

#843
US20230302090A1
Human necessities

COMBINATION THERAPY FOR TREATMENT OF CANCER

#844
US20230302091A1
Human necessities

Combination Therapy with Controlled-Release CNP Agonists

#845
US20230302092A1
Human necessities

SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID

#846 ✅ Patent 12,370,241 granted on 2025-07-29
US20230302093A1
Human necessities

NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIA

#847
US20230302094A1
Human necessities

GLP-1 RECEPTOR AGONISTS IN DEMENTIA

#848
US20230302095A1
Human necessities

INCREASING THE EFFICACY OF BIOLOGICAL THERAPEUTIC MOLECULES

#849
US20230302096A1
Human necessities

AGENTS DIRECTED AGAINST A CIS RGMA/NEOGENIN INTERACTION OR LIPID RAFTS AND USE OF THE SAME IN METHODS OF TREATMENT

#850
US20230302097A1
Human necessities

METHODS FOR TREATING OR PREVENTING TISSUE ADHESIONS

#851
US20230302098A1
Human necessities

INTESTINAL ALKALINE PHOSPHATASES AND METHODS OF USE IN INHIBITING LIVER FIBROSIS

#852
US20230302099A1
Human necessities

HYALURONIDASE FUSION PROTEINS COMPRISING A TARGETING SEQUENCE AND METHODS OF USING SAME TO TREAT A COSMETIC CONDITION

#853
US20230302100A1
Human necessities

CYSTEINE PROTEASE

#854 ✅ Patent 11,986,516 granted on 2024-05-21
US20230302101A1
Human necessities

Compositions and methods for treatment of SARS-COV-2

#855
US20230302102A1
Human necessities

METHOD AND DRUG FOR TUMOR TREATMENT

#856
US20230302103A1
Human necessities

BOTULINUM NEUROTOXIN FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCYTE HYPERACTIVITY AND/OR EXCESS MELANIN

#857
US20230302104A1
Human necessities

TREATMENT AND/OR PREVENTION OF A DISEASE OR A SYNDROME RELATED TO A VIRUS INFECTION

#858
US20230302105A1
Human necessities

SUPPRESSION OF DIABETES USING EXOSOMES FROM STEM CELL PROGRAMMED MYELOID CELLS

#859
US20230302106A1
Human necessities

TARGETED EXPANSION OF QA-1-PEPTIDE-SPECIFIC REGULATORY CD8 T CELLS TO AMELIORATE ARTHRITIS

#860 ✅ Patent 12,370,245 granted on 2025-07-29
US20230302108A1
Human necessities

ALK POLYPEPTIDES AND METHODS OF USE THEREOF

#861
US20230302109A1
Human necessities

ANTIGEN POOL

#862
US20230302110A1
Human necessities

SAPONIN CONTAINING EXTRACTS PREPARED FROM HESPERALOE USEFUL IN THE TREATMENT OF NON-HUMAN ANIMALS

#863
US20230302111A1
Human necessities

IMMUNOGENIC COMPOSITIONS COMPRISING LAWSONIA INTRACELLULARIS

#864
US20230302112A1
Human necessities

RESPIRATORY SYNCTIAL VIRUS RNA VACCINE

#865 ✅ Patent 11,896,659 granted on 2024-02-13
US20230302113A1
Human necessities

Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof

#866 ✅ Patent 11,918,641 granted on 2024-03-05
US20230302114A1
Human necessities

Chimeric influenza vaccines

#867 ✅ Patent 12,186,386 granted on 2025-01-07
US20230302115A1
Human necessities

Recombinant RSV with silent mutations, vaccines, and methods related thereto

#868
US20230302116A1
Human necessities

VARIANT SARS-CoV-2 PROTEINS AND USES THEREOF

#869
US20230302118A1
Human necessities

ORAL RECOMBINANT YEAST FOR EXPRESSING S PROTEIN OF NOVEL CORONAVIRUS, PREPARATION THEREFOR, AND APPLICATION THEREOF

#870
US20230302119A1
Human necessities

Stabilized Corona Virus Spike Protein Fusion Proteins

#871
US20230302120A1
Human necessities

PROTEINS, POLYNUCLEOTIDES, AND METHODS FOR TREATING CORONAVIRUS INFECTION

#872 ✅ Patent 12,285,481 granted on 2025-04-29
US20230302121A1
Human necessities

Methods for the treatment of COVID-19 comprising administering replication-defective adenoviruses encoding the SARS-CoV-2 spike glycoprotein and modified nucleocapsid protein

#873 ✅ Patent 11,883,486 granted on 2024-01-30
US20230302122A1
Human necessities

Coronavirus vaccine

#874
US20230302123A1
Human necessities

REPLICATION-DEFICIENT ADENOVIRUS

#875
US20230302124A1
Human necessities

BACTERIAL MICROCOMPARTMENT VIRUS-LIKE PARTICLES

#876
US20230302127A1
Human necessities

TAU VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE

#877
US20230302128A1
Human necessities

IMMUNOMODULATORY FUSION PROTEIN-METAL HYDROXIDE COMPLEXES AND METHODS THEREOF

#878
US20230302130A1
Human necessities

POLY-DONOR CD4+ T CELLS EXPRESSING IL-10 AND USES THEREOF

#879
US20230302131A1
Human necessities

MPC INHIBITION FOR PRODUCING T-CELLS WITH A MEMORY PHENOTYPE

#880
US20230302132A1
Human necessities

METHOD FOR PREPARING UNIVERSAL IMMUNE CELLS AND USE THEREOF

#881
US20230302133A1
Human necessities

TARGETED PROTEIN DEGRADATION IN THERAPEUTIC CELLS

#882
US20230302134A1
Human necessities

COMPOSITIONS AND METHODS FOR ENGINEERING AND SELECTION OF CAR T CELLS WITH DESIRED PHENOTYPES

#883
US20230302135A1
Human necessities

HYBRID ALLOSTERIC RECEPTOR-ENGINEERED STEM CELLS

#884 ✅ Patent 12,186,395 granted on 2025-01-07
US20230302136A1
Human necessities

Multiple sign bit hiding within a transform unit

#885 ✅ Patent 12,324,838 granted on 2025-06-10
US20230302137A1
Human necessities

INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE

#886 ✅ Patent 12,121,610 granted on 2024-10-22
US20230302138A1
Human necessities

Compositions and methods for targeted delivery to cells

#887
US20230302139A1
Human necessities

TARGETED RNA DEGRADATION ALLOWS PRECISION REPURPOSING OF PROTEIN-TARGETED SMALL MOLECULE MEDICINES TO RNA

#888
US20230302140A1
Human necessities

CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION

#889
US20230302142A1
Human necessities

Cytotoxic Agents

#890
US20230302144A1
Human necessities

Porphyrin Compounds and Compositions Useful for Treating Cancer

#891
US20230302145A1
Human necessities

SURFACTANT PROTEIN C MIMICS DISPLAYING PATHOGEN- OR ALLERGEN-BINDING MOIETIES

#892
US20230302146A1
Human necessities

HYBRID CARRIERS FOR NUCLEIC ACID CARGO

#893
US20230302148A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING LONG-ACTING CONJUGATE OF TRIPLE GLUCAGON/GLP-1/GIP RECEPTOR AGONIST

#894
US20230302150A1
Human necessities

ANTIBODY-TLR AGONIST CONJUGATES, METHODS AND USES THEREOF

#895
US20230302152A1
Human necessities

CYCLODEXTRIN-BASED GAMMALINOLENIC ACID FORMULATION FOR TREATMENT OF BRAIN CANCER

#896 ✅ Patent 11,951,177 granted on 2024-04-09
US20230302153A1
Human necessities

High sterol-containing lipid nanoparticles

#897
US20230302154A1
Human necessities

NANODRUGS FOR TARGETED DRUG DELIVERY AND USE THEREOF

#898
US20230302155A1
Human necessities

COMPOSITIONS AND METHODS FOR IN VIVO GENERATION OF CAR EXPRESSING CELLS

#899
US20230302156A1
Human necessities

REDOX-RESPONSIVE NANOPARTICLE COMPOSITIONS FOR OCULAR DELIVERY OF THERAPEUTICS

#900
US20230302157A1
Human necessities

Adeno-Associated Virus Vector Delivery of Muscle Specific Micro-Dystrophin to Treat Muscular Dystrophy